# An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)

> **NCT00465088** · PHASE3 · COMPLETED · sponsor: **Abbott** · enrollment: 199 (actual)

## Conditions studied

- Hyperlipidemia
- Mixed Dyslipidemia

## Interventions

- **DRUG:** Niacin ER/Simvastatin Tablets
- **DRUG:** atorvastatin

## Key facts

- **NCT ID:** NCT00465088
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2008-02
- **Final completion:** —
- **Target enrollment:** 199 (ACTUAL)
- **Last updated:** 2011-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00465088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00465088, "An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME)". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00465088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*